Literature DB >> 36085346

Cystine crystal-induced reactive oxygen species associated with NLRP3 inflammasome activation: implications for the pathogenesis of cystine calculi.

Zhang Yifan1, Shen Luming2, Chen Wei1, Xu Luwei1, Xu Zheng1, Jia Ruipeng3.   

Abstract

PURPOSE: To investigate whether cystine crystal-induced production of reactive oxygen species (ROS) and activation of NLRP3 inflammasome contribute to cystine calculi formation.
METHODS: Slc7a9-knockout rats were created as cystine calculi animal models. Kidney histological examination using TEM and immunohistochemistry were performed. The protein expression of NLRP3 and IL-1β and the concentrations of oxidative stress markers such as ROS, MDA and H2O2 in kidney tissues were estimated. In parallel, HK-2 human renal proximal tubule cells were exposed to cystine crystals and NAC treatment. The protein and mRNA expression levels of NLRP3 were evaluated. Finally, cell apoptosis and cystine crystal adherence were also assessed.
RESULTS: Activation of the NLRP3 inflammasome and marked elevations in MDA, H2O2 and ROS levels were observed both in vivo and in vitro. In particular, the protein and mRNA expression of NLRP3 was significantly increased by cystine crystals, but could be restored by an inhibitor of ROS. In addition, cell apoptosis and cystine crystal adherence were promoted by the NLRP3 inflammasome. The expression of CD44, OPN and HA in HK-2 cells was markedly increased by cystine crystals, but could be decreased by NLRP3 siRNA treatment.
CONCLUSION: Notably, we found that the activation of NLRP3 by cystine crystal-induced ROS production was of major importance in the pathogenesis of cystine calculi formation.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cystine calculi; NLRP3 inflammasome; Oxidative stress; ROS

Year:  2022        PMID: 36085346     DOI: 10.1007/s11255-022-03347-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  1 in total

1.  Treating the cystine stone former presents a singular clinical challenge.

Authors:  Thomas Chi; Eric Taylor; Marshall L Stoller
Journal:  Transl Androl Urol       Date:  2014-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.